Advanced Search
Contact | Corporate | Help

Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Carcinoma, Small Cell Lung
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: irinotecan
  • Drug: carboplatin
  • Drug: bevacizumab
Enrollment:
50

Additional information about NCT00294931.


SourceSolution © 2008-2012